Payment overview · 2025
General Payments
$120.86
1 reported records · 1 companies
Healthcare provider profile · identity verified
Malik E Ashe, MD
Allopathic & Osteopathic Physicians|Family Medicine · CHESTER, SC · NPI 1366477788
Verified facts
What the public records show
CMS Open Payments records show Malik E Ashe, MD received $120.86 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $120.86 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $120.86 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $120.86 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
42 | 11 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 421 | 110 |
| Tramadol Hcl | Tramadol Hcl | 329 | 62 |
| Atorvastatin Calcium | Atorvastatin Calcium | 313 | 87 |
| Omeprazole | Omeprazole | 286 | 79 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 265 | 59 |
| Metformin Hcl | Metformin Hcl | 246 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 241 | 58 |
| Gabapentin | Gabapentin | 226 | 56 |
| Metoprolol Succinate | Metoprolol Succinate | 201 | 43 |
| Losartan Potassium | Losartan Potassium | 192 | 58 |
| Lisinopril | Lisinopril | 190 | 45 |
| Zolpidem Tartrate | Zolpidem Tartrate | 178 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 169 | 52 |
| Levothyroxine Sodium | Levothyroxine Sodium | 161 | 38 |
| Furosemide | Furosemide | 160 | 53 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 126 | 41 |
| Diclofenac Sodium | Diclofenac Sodium | 125 | 35 |
| Pantoprazole Sodium | Pantoprazole Sodium | 114 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 113 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 112 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 109 | 32 |
| Pravastatin Sodium | Pravastatin Sodium | 107 | 24 |
| Ibuprofen | Ibuprofen | 104 | 54 |
| Simvastatin | Simvastatin | 101 | 28 |
| Celecoxib | Celecoxib | 95 | 29 |
| Ezetimibe | Ezetimibe | 94 | 29 |
| Mounjaro | Tirzepatide | 93 | 17 |
| Potassium Chloride | Potassium Chloride | 93 | 32 |
| Linzess | Linaclotide | 92 | 16 |
| Trazodone Hcl | Trazodone Hcl | 89 | 24 |
| Eliquis | Apixaban | 86 | 18 |
| Alprazolam | Alprazolam | 85 | 15 |
| Allopurinol | Allopurinol | 79 | 23 |
| Carvedilol | Carvedilol | 79 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 18 |
| Sertraline Hcl | Sertraline Hcl | 78 | 17 |
| Telmisartan | Telmisartan | 78 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 75 | 35 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 26 |
| Atenolol | Atenolol | 68 | 18 |
| Glipizide | Glipizide | 66 | 16 |
| Chlorthalidone | Chlorthalidone | 61 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 59 | 25 |
| Meclizine Hcl | Meclizine Hcl | 59 | 16 |
| Jardiance | Empagliflozin | 58 | 14 |
| Januvia | Sitagliptin Phosphate | 57 | 11 |
| Meloxicam | Meloxicam | 57 | 20 |
| Diazepam | Diazepam | 56 | suppressed |
| Temazepam | Temazepam | 56 | suppressed |
| Famotidine | Famotidine | 54 | 13 |
| Baclofen | Baclofen | 52 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 51 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 51 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | suppressed |
| Pregabalin | Pregabalin | 48 | suppressed |
| Prednisone | Prednisone | 47 | 35 |
| Azithromycin | Azithromycin | 45 | 42 |
| Clonidine Hcl | Clonidine Hcl | 45 | 12 |
| Spironolactone | Spironolactone | 45 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | 11 |
| Valsartan | Valsartan | 44 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 43 | 13 |
| Colchicine | Colchicine | 43 | 12 |
| Farxiga | Dapagliflozin Propanediol | 42 | 11 |
| Montelukast Sodium | Montelukast Sodium | 41 | 12 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 40 | suppressed |
| Glimepiride | Glimepiride | 40 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 39 | 14 |
| Indomethacin | Indomethacin | 39 | suppressed |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 38 | 12 |
| Amoxicillin | Amoxicillin | 37 | 34 |
| Fluoxetine Hcl | Fluoxetine Hcl | 36 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 36 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 33 | suppressed |
| Glipizide Er | Glipizide | 33 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 32 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 30 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 29 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Naproxen | Naproxen | 27 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 27 | suppressed |
| Lorazepam | Lorazepam | 26 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 26 | suppressed |
| Tradjenta | Linagliptin | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Carisoprodol | Carisoprodol | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 23 |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Cephalexin | Cephalexin | 24 | 23 |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Vascepa | Icosapent Ethyl | 22 | suppressed |
| Creon | Lipase/Protease/Amylase | 21 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Klor-Con M20 | Potassium Chloride | 21 | suppressed |
| Lidocaine | Lidocaine | 21 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Clotrimazole | Clotrimazole | 19 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Rybelsus | Semaglutide | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 17 | suppressed |
| Ozempic | Semaglutide | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Myrbetriq | Mirabegron | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 14 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Fluocinolone Acetonide | Fluocinolone Acetonide | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $120.86 · 1 records | AstraZeneca Pharmaceuticals LP | BREZTRI | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error